Notably, there is a relationship between genetics and pathology; an increased rate of α-syn-SAA-negative individuals carrying primary pathogenic LRRK2 (MIM: 609007) variants (it is estimated that 22%–33% of individuals with PD with LRRK2 mutations are α-syn-SAA negative19,21). This evidence concerns the gene LRRK2 and Parkinson disease.